State of Alaska Department of Revenue Sells 415 Shares of HealthEquity, Inc. $HQY

State of Alaska Department of Revenue lessened its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 4.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,721 shares of the company’s stock after selling 415 shares during the quarter. State of Alaska Department of Revenue’s holdings in HealthEquity were worth $1,018,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of the company. Public Employees Retirement System of Ohio boosted its stake in HealthEquity by 0.8% during the second quarter. Public Employees Retirement System of Ohio now owns 93,547 shares of the company’s stock worth $9,800,000 after buying an additional 733 shares in the last quarter. Sheets Smith Wealth Management lifted its holdings in shares of HealthEquity by 1.9% during the 2nd quarter. Sheets Smith Wealth Management now owns 8,419 shares of the company’s stock worth $882,000 after acquiring an additional 157 shares during the period. Covea Finance boosted its position in shares of HealthEquity by 22.5% during the 2nd quarter. Covea Finance now owns 39,200 shares of the company’s stock valued at $4,107,000 after acquiring an additional 7,200 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of HealthEquity by 27.7% during the 2nd quarter. GAMMA Investing LLC now owns 2,006 shares of the company’s stock valued at $210,000 after acquiring an additional 435 shares in the last quarter. Finally, ABLE Financial Group LLC increased its stake in HealthEquity by 14.0% in the second quarter. ABLE Financial Group LLC now owns 25,845 shares of the company’s stock valued at $2,708,000 after acquiring an additional 3,174 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Price Performance

Shares of HQY stock opened at $88.59 on Monday. HealthEquity, Inc. has a 1 year low of $74.07 and a 1 year high of $116.65. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. The firm’s 50 day moving average is $92.15 and its 200-day moving average is $93.85. The firm has a market capitalization of $7.63 billion, a price-to-earnings ratio of 53.69, a PEG ratio of 1.27 and a beta of 0.47.

Insider Activity at HealthEquity

In other news, EVP Delano Ladd sold 6,000 shares of HealthEquity stock in a transaction on Friday, September 19th. The stock was sold at an average price of $94.11, for a total value of $564,660.00. Following the completion of the sale, the executive vice president directly owned 79,456 shares of the company’s stock, valued at approximately $7,477,604.16. This trade represents a 7.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on HQY shares. Barrington Research reaffirmed an “outperform” rating and set a $125.00 price objective on shares of HealthEquity in a report on Friday, August 29th. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a research report on Saturday, September 27th. JPMorgan Chase & Co. boosted their price target on HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, September 3rd. Jefferies Financial Group upped their price target on HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, September 3rd. Finally, Royal Bank Of Canada lifted their price objective on HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, September 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and an average price target of $119.77.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.